• Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial

• Database of all ivermectin COVID-19 studies. 107 studies, 71 peer reviewed, 61 with results comparing treatment and control groups

• Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

• Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review

• Database of all HCQ COVID-19 studies. 325 studies, 239 peer reviewed, 272 comparing treatment and control groups

• HCQ for Covid-19: real-time meta analysis of 272 studies

• Covid-19: Lancet retracts paper that halted hydroxychloroquine trials This article is more than 1 year

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial

Database of all ivermectin COVID-19 studies. 107 studies, 71 peer reviewed, 61 with results comparing treatment and control groups

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review

Database of all HCQ COVID-19 studies. 325 studies, 239 peer reviewed, 272 comparing treatment and control groups

HCQ for Covid-19: real-time meta analysis of 272 studies

Covid-19: Lancet retracts paper that halted hydroxychloroquine trials This article is more than 1 year